Boston’s XenoTherapeutics Prepares to Donate Xeno-Skin™ to Burn Victims of New Zealand

December 19, 2019

XenoTherapeutics, Inc. a clinical-stage biotechnology company focused on immunogenomic reprogramming of swine organs and tissues for human use, announced their readiness to supply victims of New Zealand’s White Island volcano tragedy with Xeno-Skin™, a live-cell product derived from genetically-engineered swine and cleared by the FDA for investigational use in human patients suffering severe and extensive burn wounds

Contact Us

359 Newbury Street, 5th Floor Suite 526

Boston, MA 02115


Connect with us

Federal EIN Number: 81-1016095

© 2020 by XenoTherapeutics Foundation

  • Black Facebook Icon
  • Black Twitter Icon
  • LinkedIn